International Stem Cell Corp Sustainability Reports
International Stem Cell Corporation is a clinical-stage biotechnology company focused on therapeutic applications of human parthenogenetic stem cells. The company develops cell-based therapeutics for diseases such as Parkinson's disease and manufactures specialized biomedical research products.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001SF7005
2 reports from 2013 to 2022
